SFS
SRNE

Sowell Financial Services’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Sowell Financial Services’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,363
Closed -$45K – 3025
2021
Q1 		$45K Buy
6,363
+2,955
+87% +$31.2K ﹤0.01% 1705
2020
Q4 		$23K Buy
3,408
+762
+29% +$6.12K ﹤0.01% 1690
2020
Q3 		$30K Buy
2,646
+496
+23% +$4.54K ﹤0.01% 1388
2020
Q2 		$14K Buy
2,150
+150
+8% +$574 ﹤0.01% 1587
2020
Q1 		$4K Hold
2,000
– – ﹤0.01% 1941
2019
Q4 		$7K Buy
+2,000
New +$4.77K ﹤0.01% 1818

Other funds holding SRNE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Sowell Financial Services's SRNE Position: Q2 2021 in Review

Sowell Financial Services sold out of Sorrento Therapeutics, Inc. (SRNE) in Q2 2021, closing a stake of 6,363 shares — an estimated $45K sold.

Sowell Financial Services first reported a position in SRNE in Q4 2019 and held it in 6 quarters. The position peaked at $45K in Q1 2021. 212 funds tracked by Wall St. Rank hold SRNE as of Q2 2021.

  • Sowell Financial Services reported no remaining Sorrento Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 6,363 Sorrento Therapeutics, Inc. shares in Q2 2021, an estimated $45K.
  • Sowell Financial Services first reported a position in Sorrento Therapeutics, Inc. in Q4 2019 and held it in 6 quarters.
  • Sowell Financial Services's Sorrento Therapeutics, Inc. position peaked at $45K in Q1 2021.
  • 212 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.